Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors.

Source:http://linkedlifedata.com/resource/pubmed/id/15614706

Clin. Infect. Dis. 2005 Jan 1 40 1 158-63

Download in:

View as

General Info

PMID
15614706